Global-e Announces Closing of Acquisition of Flow Commerce and Expansion of its Leadership Team

Written by Customer Service on January 4, 2022. Posted in Mergers And Acquisitions.

The acquisition is expected to strengthen Global-e’s platform offering for emerging brands and is intended to further expand its capabilities and customer base in the segment PETAH-TIKVA, Israel, Jan. 04, 2022 (GLOBE NEWSWIRE) — Global-e (NASDAQ: GLBE) (“Global-e” or the “Company”), the world’s leading cross-border end-to-end platform for brands and retailers, today announced the closing of its previously reported acquisition of Flow Commerce Inc. (“Flow”), a technology based cross-border e-commerce software solution for emerging brands. Leveraging Flow’s robust API-based technology, Global-e will be well-positioned to provide small merchants with a best-in-class solution, tailored for the needs of emerging brands, with a lightweight integration effort and advanced self-service capabilities, in combination with Global-e’s unique...

Freeline To Participate In Conferences During January 2022

Written by Customer Service on January 4, 2022. Posted in Public Companies.

LONDON, Jan. 04, 2022 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) (the “Company” or “Freeline”), a clinical-stage biotechnology company developing transformative AAV-mediated gene therapies for patients suffering from inherited systemic debilitating diseases, today announced that Chief Executive Officer Michael Parini is scheduled to deliver a corporate presentation at both of the following virtual conferences: H.C. Wainwright BioConnect Conference, where an on-demand webcast will be available on January 10, 2022, starting at 7:00 a.m. EST. 40th Annual J.P. Morgan Healthcare Conference where a live audio webcast of the presentation will be available on January 13, 2022, at 10:30 a.m. EST. The Company presentations will be available on the Investors section of the Company’s...

Oncternal Therapeutics Announces Agreement with U.S. FDA on Phase 3 Registrational Study Design for Zilovertamab in the Treatment of Mantle Cell Lymphoma

Written by Customer Service on January 4, 2022. Posted in Public Companies.

The company reached consensus with the FDA on the design and major details of the Phase 3 superiority Study ZILO-301, to treat patients with relapsed or refractory MCL with zilovertamab plus ibrutinib The FDA also provided positive feedback on the proposed key clinical and regulatory requirements of Oncternal’s development program for zilovertamab in MCL Global registrational Study ZILO-301 is expected to be initiated in the second quarter of 2022 Oncternal Therapeutics will host a conference call today at 4:30 p.m. ET to provide further details SAN DIEGO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that following a successful End-of-Phase 2 meeting with the U.S. Food and Drug Administration...

Nocturne Luxury Villas, Backed by Gladstone Investment Corporation, Announces Third in a Series of Investments in the Luxury Vacation Rental Sector with the Acquisition of West Indies Management Company (WIMCO Villas)

Written by Customer Service on January 4, 2022. Posted in Mergers And Acquisitions.

WIMCO Villas St Barts A private WIMCO villa rental in St Barts with 24/7 concierge service MCLEAN, VA, Jan. 04, 2022 (GLOBE NEWSWIRE) — Nocturne Luxury Villas (“Nocturne” or the “Company”), together with Gladstone Investment Corporation (NASDAQ: GAIN) (“Gladstone Investment”), acquired West Indies Management Company, a leading villa rental manager on the island of Saint Barthélemy in the French West Indies, including its sister company based in St. Jean, WIMCOsbh (“WIMCO”). This investment is the third by Nocturne who last year announced its acquisition of Exceptional Stays based in Telluride, CO and St. Barth Properties. WIMCO Villas was founded in 1983 by Brook Lacour. In 1984, Tim Warburton partnered with sister-in-law Lacour to build a villa rental market for travelers to St. Barths, out of a U.S. office based...

Harris acquires i2 product portfolio from IBM

Written by Customer Service on January 4, 2022. Posted in Mergers And Acquisitions.

OTTAWA, Ontario and CAMBRIDGE, United Kingdom, Jan. 04, 2022 (GLOBE NEWSWIRE) — Harris, a global vertical market software provider, has acquired the i2 intelligence analysis product portfolio of IBM, including the i2 Analyst’s Notebook, i2 Enterprise Insight Analysis (EIA) and i2 iBase platforms. The acquisition positions Harris to further deliver mission-critical applications for national defense, state & local law enforcement, maritime security as well as evidence management. i2’s advanced analytics and intelligence analysis tools, such as the industry leading i2 Analyst’s Notebook, help analysts transform data into decisions in near-real-time, uncover hidden connections with visual displays, and turn overwhelming and disparate data—regardless of the source—into actionable intelligence. The i2 product portfolio, i2 executives...

World Insurance Associates Acquires Southern Cross Insurance Solutions

Written by Customer Service on January 4, 2022. Posted in Mergers And Acquisitions.

Tinton Falls, NJ, Jan. 04, 2022 (GLOBE NEWSWIRE) — World Insurance Associates LLC (“WIA”), a Top 100 Insurance Brokerage, announced today that it acquired Southern Cross Insurance Solutions LLC (“Southern Cross”) of Orlando, FL on December 31, 2021. Terms of the transaction were not disclosed. Ann A. Geisler established Southern Cross Insurance Solutions in 2013. Today, Southern Cross is an insurance agency expanding personalized insurance solutions for birth centers and midwives in all settings across the United States. Southern Cross pioneered The Midwife Plan, a specialized Professional and General Liability insurance policy that was created for birth centers and allied healthcare professionals. “We are pleased to join World Insurance Associates,” said Ann A. Geisler, President, Southern Cross. “We ensure the very best in insurance...

2021 Year-End NAIC Designations for STACR Debt, STACR Trust, and STACR REMIC Trust Notes

Written by Customer Service on January 4, 2022. Posted in Public Companies.

MCLEAN, Va., Jan. 04, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today published on its website the National Association of Insurance Commissioners (NAIC) 2021 filing year designations for certain STACR Debt, STACR Trust, and STACR REMIC Trust notes. Freddie Mac expects to receive NAIC Designations for certain STACR REMIC Trust 2021-DNA6, STACR REMIC Trust 2021-DNA7, STACR REMIC Trust 2021-HQA3, and STACR REMIC Trust 2021-HQA4 notes in the near future. When the NAIC Designations are available for certain notes in these four transactions, the NAIC Designations will be appended to the 2021 year-end NAIC designation file which is available on our website. About Freddie Mac Single-Family Credit Risk Transfer Freddie Mac’s Single-Family Credit Risk Transfer (CRT) programs transfer credit risk away from U.S. taxpayers to global...

KS Bancorp, Inc. (KSBI) and KS Bank, Inc. Announces Executive Leadership Plan of Transition

Written by Customer Service on January 4, 2022. Posted in Public Companies.

SMITHFIELD, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) — The Board of Directors of KS Bancorp, Inc. (the “Company”) (OTC Pink: KSBI), parent company of KS Bank, Inc. (the “Bank”), jointly announce today an executive leadership plan of transition. Effective immediately, Harold T. Keen who has been President and CEO of KS Bank since July 1990 will transition to Executive Vice Chairman of KS Bank. Mr. Keen will remain as President and CEO of KS Bancorp, Inc. Earl W. Worley, Jr., who is currently serving as the Bank’s Chief Operating Officer of KS Bank will become President and CEO of KS Bank. Mr. Worley has 30 years of bank management experience and has been in his current role since 2010. Prior to being appointed as Chief Operating Officer, Mr. Worley served as the Bank’s Chief Financial Officer from 1999 until 2010. Dit L. Breault who...

GCC Announces Q4 2021 Conference Call Details

Written by Customer Service on January 4, 2022. Posted in Public Companies.

CHIHUAHUA, Mexico, Jan. 04, 2022 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading producer of cement and concrete in the United States and Mexico, will host a conference call to review its fourth quarter 2021 earnings results on Wednesday, January 26 at 11:00 a.m. (ET). Earnings results for the quarter ended December 31, 2021, will be released on Tuesday, January 25, after market close. The call will be hosted by Enrique Escalante, CEO, and Luis Carlos Arias, CFO, and can be accessed by dialing +1 (877) 407 0789 or +1 (201) 689 8562 for international calls. The conference ID is 13725698. The presentation and listen-only webcast will be available via the following link. A replay of the webcast will be available the same day at 2:00 p.m. (ET) until February 2 at 11:59 p.m. (ET). The replay can be accessed through this...

Recylex S.A. – Total number of voting rights and shares forming the share capital as at December 31, 2021

Written by Customer Service on January 4, 2022. Posted in Public Companies.

Article L 233-8 II of the Commercial Code (Code de Commerce) and article 223-16 of the AMF General Regulation (Règlement Général de l’Autorité des Marchés Financiers) December 31, 2021 Total number of shares 25 886 482 Total number of theoretical voting rights(including suspended voting rights attached to treasury shares) 27 284 529 Total number of exercisable voting rights 27 260 590 — Media & Investor contact: T +33 (0)1 58 47 29 91 | E info@recylex.eu Recylex S.A. | Registered office: 6 place de la Madeleine | 75008 Paris | France Administrative office: 79 rue Jean-Jacques Rousseau | 92158 Suresnes Cedex | France Attachment Recylex S.A. – Total number of voting rights and shares forming the share capital as at December 31, 2021

Day: January 4, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice